메뉴 건너뛰기




Volumn 20, Issue 5, 2014, Pages 584-590

No increase in blood transfusions during liver transplantation since the withdrawal of aprotinin

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; HEMOSTATIC AGENT;

EID: 84899522808     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23839     Document Type: Conference Paper
Times cited : (32)

References (22)
  • 1
    • 0024413449 scopus 로고
    • Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation
    • Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE,. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47: 978-984.
    • (1989) Transplantation , vol.47 , pp. 978-984
    • Porte, R.J.1    Bontempo, F.A.2    Knot, E.A.3    Lewis, J.H.4    Kang, Y.G.5    Starzl, T.E.6
  • 2
    • 0025063231 scopus 로고
    • Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation
    • Mallett SV, Cox D, Burroughs AK, Rolles K,. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. Lancet 1990; 336: 886-887.
    • (1990) Lancet , vol.336 , pp. 886-887
    • Mallett, S.V.1    Cox, D.2    Burroughs, A.K.3    Rolles, K.4
  • 3
    • 0034655629 scopus 로고    scopus 로고
    • Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study
    • EMSALT Study Group.
    • Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 2000; 355: 1303-1309.
    • (2000) Lancet , vol.355 , pp. 1303-1309
    • Porte, R.J.1    Molenaar, I.Q.2    Begliomini, B.3    Groenland, T.H.4    Januszkiewicz, A.5    Lindgren, L.6
  • 4
    • 41149127789 scopus 로고    scopus 로고
    • Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: A meta-analysis on aprotinin
    • Liu CM, Chen J, Wang XH,. Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin. World J Gastroenterol 2008; 14: 1425-1429.
    • (2008) World J Gastroenterol , vol.14 , pp. 1425-1429
    • Liu, C.M.1    Chen, J.2    Wang, X.H.3
  • 5
    • 31344467254 scopus 로고    scopus 로고
    • The risk associated with aprotinin in cardiac surgery
    • for Multicenter Study of Perioperative Ischemia Research Group and Ischemia Research and Education Foundation.
    • Mangano DT, Tudor IC, Dietzel C,; for Multicenter Study of Perioperative Ischemia Research Group and Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-365.
    • (2006) N Engl J Med , vol.354 , pp. 353-365
    • Mangano, D.T.1    Tudor, I.C.2    Dietzel, C.3
  • 6
    • 44349089188 scopus 로고    scopus 로고
    • A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
    • et al.; for BART Investigators.
    • Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al.; for BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331.
    • (2008) N Engl J Med , vol.358 , pp. 2319-2331
    • Fergusson, D.A.1    Hébert, P.C.2    Mazer, C.D.3    Fremes, S.4    MacAdams, C.5    Murkin, J.M.6
  • 7
    • 79959474965 scopus 로고    scopus 로고
    • Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: Single-center experience
    • Trzebicki J, Kosieradzki M, Flakiewicz E, Kuzminska G, Wasiak D, Pacholczyk M, et al. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience. Transplant Proc 2011; 43: 1725-1727.
    • (2011) Transplant Proc , vol.43 , pp. 1725-1727
    • Trzebicki, J.1    Kosieradzki, M.2    Flakiewicz, E.3    Kuzminska, G.4    Wasiak, D.5    Pacholczyk, M.6
  • 8
    • 33645321129 scopus 로고    scopus 로고
    • Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation
    • Ickx BE, van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 2006; 46: 595-605.
    • (2006) Transfusion , vol.46 , pp. 595-605
    • Ickx, B.E.1    Van Der Linden, P.J.2    Melot, C.3    Wijns, W.4    De Pauw, L.5    Vandestadt, J.6
  • 9
    • 79958250005 scopus 로고    scopus 로고
    • Aprotinin versus tranexamic acid during liver transplantation: Impact on blood product requirements and survival
    • Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Roy A,. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation 2011; 91: 1273-1278.
    • (2011) Transplantation , vol.91 , pp. 1273-1278
    • Massicotte, L.1    Denault, A.Y.2    Beaulieu, D.3    Thibeault, L.4    Hevesi, Z.5    Roy, A.6
  • 10
    • 33845651348 scopus 로고    scopus 로고
    • Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis
    • Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ,. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7: 185-194.
    • (2007) Am J Transplant , vol.7 , pp. 185-194
    • Molenaar, I.Q.1    Warnaar, N.2    Groen, H.3    Tenvergert, E.M.4    Slooff, M.J.5    Porte, R.J.6
  • 12
    • 1242329511 scopus 로고    scopus 로고
    • Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?
    • Ramsay MA, Randall HB, Burton EC,. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated? Liver Transpl 2004; 10: 310-314.
    • (2004) Liver Transpl , vol.10 , pp. 310-314
    • Ramsay, M.A.1    Randall, H.B.2    Burton, E.C.3
  • 13
    • 34548303791 scopus 로고    scopus 로고
    • The impact of aprotinin on renal function after liver transplantation: An analysis of 1,043 patients
    • Warnaar N, Mallett SV, de Boer MT, Rolando N, Burroughs AK, Nijsten MW, et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Am J Transplant 2007; 7: 2378-2387.
    • (2007) Am J Transplant , vol.7 , pp. 2378-2387
    • Warnaar, N.1    Mallett, S.V.2    De Boer, M.T.3    Rolando, N.4    Burroughs, A.K.5    Nijsten, M.W.6
  • 14
    • 0023204701 scopus 로고
    • Effect of aprotinin on need for blood transfusion after repeat open-heart surgery
    • Royston D, Bidstrup BP, Taylor KM, Sapsford RN,. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-1291.
    • (1987) Lancet , vol.2 , pp. 1289-1291
    • Royston, D.1    Bidstrup, B.P.2    Taylor, K.M.3    Sapsford, R.N.4
  • 17
    • 68349131341 scopus 로고    scopus 로고
    • Aprotinin and the risk of thrombotic complications after liver transplantation: A retrospective analysis of 1492 patients
    • Warnaar N, Mallett SV, Klinck JR, de Boer MT, Rolando N, Burroughs AK, et al. Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients. Liver Transpl 2009; 15: 747-753.
    • (2009) Liver Transpl , vol.15 , pp. 747-753
    • Warnaar, N.1    Mallett, S.V.2    Klinck, J.R.3    De Boer, M.T.4    Rolando, N.5    Burroughs, A.K.6
  • 18
    • 0033917175 scopus 로고    scopus 로고
    • Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation
    • Dalmau A, Sabaté A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000; 91: 29-34.
    • (2000) Anesth Analg , vol.91 , pp. 29-34
    • Dalmau, A.1    Sabaté, A.2    Acosta, F.3    Garcia-Huete, L.4    Koo, M.5    Sansano, T.6
  • 19
    • 33749055499 scopus 로고    scopus 로고
    • Coagulation management during liver transplantation [in German]
    • Görlinger K,. Coagulation management during liver transplantation [in German]. Hamostaseologie 2006; 26 (suppl 1): S64-S76.
    • (2006) Hamostaseologie , vol.26 , Issue.SUPPL. 1
    • Görlinger, K.1
  • 20
    • 84863956158 scopus 로고    scopus 로고
    • Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation
    • Broomhead RH, Patel S, Fernando B, O'Beirne J, Mallett S,. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transpl 2012; 18: 771-778.
    • (2012) Liver Transpl , vol.18 , pp. 771-778
    • Broomhead, R.H.1    Patel, S.2    Fernando, B.3    O'Beirne, J.4    Mallett, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.